Related Experiment Videos

Clindamycin-associated colitis

The American Journal of Digestive Diseases
|March 1, 1975
PubMed

Insights

Clindamycin-associated colitis can cause prolonged diarrhea and mucosal damage weeks after antibiotic discontinuation. Physicians should consider this diagnosis in patients experiencing diarrhea during clindamycin therapy.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Clindamycin is an antibiotic with known gastrointestinal side effects.
  • Antibiotic-associated colitis is a serious condition with potential for significant morbidity and mortality.

Purpose of the Study:

  • To report four cases of clindamycin-associated colitis observed at Kansas University Medical Center.
  • To highlight the clinical presentation and diagnostic considerations for this adverse drug reaction.

Main Methods:

  • Case series reporting on four patients who developed colitis after clindamycin treatment.
  • Review of clinical data including onset of symptoms, duration, and endoscopic findings.

Main Results:

  • All four patients experienced diarrhea 7-14 days after starting clindamycin.
  • Diarrhea persisted for weeks even after discontinuing the antibiotic.
  • Endoscopic examination revealed mucosal changes ranging from focal ulceration to pseudomembrane formation.

Conclusions:

  • Diarrhea in patients receiving clindamycin should prompt consideration of antibiotic-induced colitis.
  • Early recognition and diagnosis are crucial for managing this potentially severe condition.

Related Concept Videos